| Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions JA Roberts, MH Abdul-Aziz, J Lipman, JW Mouton, AA Vinks, TW Felton, ... The Lancet infectious diseases 14 (6), 498-509, 2014 | 1002* | 2014 |
| Antimicrobial therapeutic drug monitoring in critically ill adult patients: a Position Paper# MH Abdul-Aziz, JWC Alffenaar, M Bassetti, H Bracht, G Dimopoulos, ... Intensive care medicine 46, 1127-1153, 2020 | 616* | 2020 |
| Continuous versus intermittent β-lactam infusion in severe sepsis. A meta-analysis of individual patient data from randomized trials JA Roberts, MH Abdul-Aziz, JS Davis, JM Dulhunty, MO Cotta, J Myburgh, ... American journal of respiratory and critical care medicine 194 (6), 681-691, 2016 | 409 | 2016 |
| Beta-Lactam Infusion in Severe Sepsis (BLISS): a prospective, two-centre, open-labelled randomised controlled trial of continuous versus intermittent beta-lactam infusion in … MH Abdul-Aziz, H Sulaiman, MB Mat-Nor, V Rai, KK Wong, MS Hasan, ... Intensive care medicine 42, 1535-1545, 2016 | 309 | 2016 |
| Applying pharmacokinetic/pharmacodynamic principles in critically ill patients: optimizing efficacy and reducing resistance development MH Abdul-Aziz, J Lipman, JW Mouton, WW Hope, JA Roberts Seminars in respiratory and critical care medicine 36 (01), 136-153, 2015 | 184 | 2015 |
| Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An … MH Abdul-Aziz, J Lipman, M Akova, M Bassetti, JJ De Waele, ... Journal of Antimicrobial Chemotherapy 71 (1), 196-207, 2016 | 167 | 2016 |
| Optimising drug dosing in patients receiving extracorporeal membrane oxygenation V Cheng, MH Abdul-Aziz, JA Roberts, K Shekar Journal of thoracic disease 10 (Suppl 5), S629, 2018 | 129 | 2018 |
| Continuous beta-lactam infusion in critically ill patients: the clinical evidence MH Abdul-Aziz, JM Dulhunty, R Bellomo, J Lipman, JA Roberts Annals of Intensive Care 2, 1-16, 2012 | 115 | 2012 |
| Prolonged infusion piperacillin-tazobactam decreases mortality and improves outcomes in severely ill patients: results of a systematic review and meta-analysis NJ Rhodes, J Liu, JN O’Donnell, JM Dulhunty, MH Abdul-Aziz, PY Berko, ... Critical care medicine 46 (2), 236-243, 2018 | 105 | 2018 |
| Infections by multidrug-resistant Gram-negative Bacteria: What's new in our arsenal and what's in the pipeline? D Koulenti, A Song, A Ellingboe, MH Abdul-Aziz, P Harris, E Gavey, ... International journal of antimicrobial agents 53 (3), 211-224, 2019 | 90 | 2019 |
| Prolonged administration of β-lactam antibiotics–a comprehensive review and critical appraisal M Osthoff, M Siegemund, G Balestra, MH Abdul-Aziz, JA Roberts Swiss medical weekly 146 (4142), w14368-w14368, 2016 | 75 | 2016 |
| Continuous infusion vs. bolus dosing: implications for beta-lactam antibiotics. MH AA, CE Staatz, CM Kirkpatrick, J Lipman, JA Roberts Minerva anestesiologica 78 (1), 94-104, 2011 | 75 | 2011 |
| Antibiotic dosing during extracorporeal membrane oxygenation: does the system matter? MH Abdul-Aziz, JA Roberts Current Opinion in Anesthesiology 33 (1), 71-82, 2020 | 58 | 2020 |
| What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients? AS Alobaid, A Brinkmann, OR Frey, AC Roehr, S Luque, S Grau, G Wong, ... Journal of Antimicrobial Chemotherapy 71 (3), 696-702, 2016 | 48 | 2016 |
| What are the current approaches to optimising antimicrobial dosing in the intensive care unit? MG Chai, MO Cotta, MH Abdul-Aziz, JA Roberts Pharmaceutics 12 (7), 638, 2020 | 41 | 2020 |
| Therapeutic drug monitoring of antibiotics: defining the therapeutic range MH Abdul–Aziz, K Brady, MO Cotta, JA Roberts Therapeutic drug monitoring 44 (1), 19-31, 2022 | 39 | 2022 |
| Increasing ventilator surge capacity in COVID 19 pandemic: design, manufacture and in vitro–in vivo testing in anaesthetized healthy pigs of a rapid prototyped mechanical … J Dhanani, G Pang, J Pincus, B Ahern, W Goodwin, N Cowling, G Whitten, ... BMC research notes 13, 1-6, 2020 | 32 | 2020 |
| Overcoming barriers to optimal drug dosing during ECMO in critically ill adult patients V Cheng, MH Abdul-Aziz, JA Roberts, K Shekar Expert opinion on drug metabolism & toxicology 15 (2), 103-112, 2019 | 31 | 2019 |
| Defining antibiotic dosing in lung infections JA Jamal, MH Abdul-Aziz, J Lipman, JA Roberts Clinical Pulmonary Medicine 20 (3), 121-128, 2013 | 29 | 2013 |
| Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC project M Delgado-Valverde, E Torres, A Valiente-Mendez, B Almirante, ... Journal of Antimicrobial Chemotherapy 71 (2), 521-530, 2016 | 26 | 2016 |
